The β-Secretase BACE1 in Alzheimer’s Disease
Harald Hampel(Eisai (United States)), Andrea Vergallo(Eisai (United States))
Cited by 657
Related Papers
The Amyloid-β Pathway in Alzheimer’s Disease
|Molecular Psychiatry|2021|1.8k
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
|Neuron|2023|235
Designing the next-generation clinical care pathway for Alzheimer’s disease
|Nature Aging|2022|193